Updated:
Facet Life Sciences
SCIENTIFIC AND REGULATORY EXPERTISE TO GET YOU TO AND THROUGH FDA | Facet Life Sciences is a trusted, award-winning regulatory affairs and product development...
Facet Life Sciences
SCIENTIFIC AND REGULATORY EXPERTISE TO GET YOU TO AND THROUGH FDA | Facet Life Sciences is a trusted, award-winning regulatory affairs and product development consulting firm, purpose-built for small life science companies. Our team brings authentic, science-first expertise to help emerging pharmaceutical, biotechnology, and medical device companies navigate the complex path to and through the US FDA.
General information
Firm type
Asset Manager
Location
Region
North America
Country
United States
City
Wayne
Corporate office
Wayne, PA, United States
Additional offices
Portland, OR · Lake Oswego, OR · San Mateo, CA · Bend, OR
Principals
Ken VanLuvanee
CEO and Board Chairman
Lisa Jenkins VanLuvanee, Ph.D.
Chief Values Officer
Sector focus
Frequently asked questions
Who runs investment decisions at Facet Life Sciences?
Ken VanLuvanee serves as CEO and Board Chairman. The firm has not disclosed any separate investment committee or CIO role; its activities appear to focus on regulatory consulting rather than asset management.
Does Facet Life Sciences participate in fund commitments or only direct deals?
Facet Life Sciences reports no fund commitments. Its operations are limited to providing regulatory, medical writing, statistical, and asset valuation services to life science companies.
What investment stages does Facet Life Sciences typically target?
Facet's website outlines support across the full product development lifecycle, from discovery and preclinical research through clinical trials, IND/IDE submissions, marketing applications, and commercial launch. It does not specify a preferred stage for engagement.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on asset managers?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: